您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION UTILIZING PANCREATIC CELL PROLIFERATION FACTOR
专利权人:
TOKYO INSTITUTE OF TECHNOLOGY
发明人:
IMAI, TAKESHI,HANDA, HIROSHI
申请号:
EP11798001
公开号:
EP2583693A4
申请日:
2011.06.13
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
Disclosed are a pharmaceutical composition, a screening method, and the like which use UDP-glucose glycoprotein glycosyl transferase 1 (UGGT1) or a gene encoding the same. UGGT1 has an extremely high proliferative activity compared to known pancreatic β-cell proliferation factors thus, UGGT1 can act as a useful therapeutic agent for diabetes without any modification and is also useful as a target substance for the development of a new therapeutic agent for diabetes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充